Allegro Biotech
Signal active
Organization
Contact Information
Overview
Allegro was founded in 2021 with the ultimate vision to augment humanity and prolong life, engineering the body atom-by-atom, blending nanotech and biotech. The company developed a promising nanotechnology platform for rheumatology, immunology and chronic degenerative diseases. Allegro brings Xyletra to the market, the world's first disease-modifying treatment for osteoarthritis, featuring injectable polypeptide nanoparticles to modulate inflammation, pain and preserve cartilage.
About
Industries
Biotechnology, Life Science, Medical, Nanotechnology
Founded
2021
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Allegro Biotech headquartered in Europe, operates in the Biotechnology, Life Science, Medical, Nanotechnology sector. The company focuses on Biotechnology and has secured $247.4M in funding across 32 round(s). With a team of 11-50 employees, Allegro Biotech is actively contributing to advancements in Biotechnology. Their latest funding round, Pre Seed Round - Allegro Biotech, raised $1.7M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$7.7M
Details
2
Allegro Biotech has raised a total of $7.7M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 6.0M | ||
| 2021 | Seed | 1.7M |
Investors
Allegro Biotech is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Allegro Biotech | - | FUNDING ROUND - Allegro Biotech | 6.0M |
| Meusinvest (Noshaq) | - | FUNDING ROUND - Meusinvest (Noshaq) | 6.0M |
| Allegro Biotech | - | FUNDING ROUND - Allegro Biotech | 1.7M |
| KBC | - | FUNDING ROUND - KBC | 1.7M |
Recent Activity
There is no recent news or activity for this profile.